News archive

Researchers at Karolinska Institutet and the University of Sussex have discovered that the process of copying DNA generates a brake signal that stalls cell division. This molecular brake ensures that the cell has two complete copies of DNA before it divides and thus prevents DNA damage and cancer development. The study is published in the scientific journal Molecular Cell.

MTC researcher Kaisa Lehti is featured on AcademiaNet, after a nomination by the Swedish Research Council.

On 6-7 June 2018, a team from Karolinska Institutet participated in the 18-months review meeting of the Horizon 2020-funded IMPACT TB project. IMPACT TB is about the implementation, evaluation and scale-up of active tuberculosis (TB) case finding and social support interventions in Nepal and Vietnam.

Daniel C. Andersson, researcher at the Department of Physiology and Pharmacology, and clinical cardiologist at Karolinska University Hospital, has been awarded the ‘Harald and Greta Jeansson Foundation Research Award 2018’. The ceremony took place on May 22, 2018.

Per-Olof Berggren, Professor of Experimental Endocrinology and Research Group Leader of the group Signal Transduction at the Department of Molecular Medicine and Surgery has been elected member of the Korean Academy of Science and Technology, KAST.

Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.

New research in an article in PLoS Pathogens this week from authors Xiaogang Feng, Susanne Nylén, Cajsa Classon, Antonio Rothfuchs, Ulf Ribacke and Jonathan Coquet at MTC suggests that chronic infection with intestinal worms makes the Bacille Calmette-Guerin (BCG) vaccine for tuberculosis less effective.